Jonathan Peacock

Jonathan Peacock is a globally recognized executive with broad experience in Biopharmaceuticals, strategy and finance.

Mr. Peacock is the former CFO of Amgen Inc. based in California and prior to that CFO of the Pharmaceuticals Division of Novartis AG, based in Switzerland. Before joining the pharmaceuticals industry, he was a partner at McKinsey and Co, where he was co-head of the European Corporate Finance practice, and was also a partner at Price Waterhouse in London and New York.

Mr. Peacock is currently the Lead Independent Director at Avantor, Board member and Chair of the Audit and Finance Committee at UCB, Board member at Genmab and at Real Chemistry. Previously he was co founder and Chairman of Arix Bioscience plc and of Bellerophon Therapeutics. From 2014 he was Board member and Audit and Finance Committee Chair at Kite Pharma, until its sale to Gilead for $11.9 billion in 2017.

Mr. Peacock is a graduate of the University of St Andrews in Scotland.